Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise - Stenlöf, K.; Cefalu, W. T.; Kim, K.-A.; Alba, M.; Usiskin, K.; Tong, C.; Canovatchel, W.; Meininger, G. (Diabetes, obesity & metabolism, 2013)
Keywords: Adolescent; Adult; Aged; Aged, 80 and over; Blood Glucose - drug effects; Blood Glucose - metabolism; Canagliflozin; Cholesterol; Cholesterol, HDL - blood; Diabetes; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - drug therapy; Diabetes Mellitus, Type 2 - epidemiology; Diet; Double-Blind Method; Drug therapy; Exercise; Fasting; Female; Glucosides - therapeutic use; Humans; Hypoglycemic Agents - therapeutic use; Male; Middle Aged; Original; phase 3 study; Postprandial Period; SGLT2 inhibitor; Sodium-Glucose Transporter 2 - antagonists & inhibitors; Thiophenes - therapeutic use; Treatment Outcome; Triglycerides - blood; type 2 diabetes; Weight Loss - drug effects